课题基金 / 基金详情

项目摘要

项目成果

CATHERINE M KOTZ的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):肥胖和超重影响大多数美国人,但也有一些人抵制肥胖,就像一些动物抵制肥胖一样。动物和人类的研究表明,自发的身体活动(SPA)产生非运动活动产热(NEAT),是防止体重增加的重要防御措施。大脑机制控制着SPA的水平,并由此产生整齐的SPA,但具体细节尚不确定。我们认为下丘脑增食欲素A(OXA)是SPA调节通路的重要组成部分,对OXA信号增强SPA和NEAT的敏感性有助于决定肥胖倾向。这项应用的目的是检验以下假设:(1)OXA介导的SPA升高可以防止体重增加,(2)肥胖抵抗(OR)大鼠OXA介导的SPA增加是由于增食欲素受体表达增加所致。我们的长期目标是利用SPA的知识和整齐的调控途径来指导肥胖人类对这些机制的治疗干预。我们计划三个目标:目的1)表征对SPA重要的增食欲素神经元亚群。A)在食欲素神经元亚群中,食欲素信息和多肽是否存在品系差异?B)食欲素神经元亚群的破坏是否会影响SPA?目的2)确定OXA介导的SPA对体重增加的重要性。A)OR大鼠RLHOXA作用减少是否降低了对体重增加的抵抗力?B)大剂量OXA刺激RLH诱导的SPA是否能减少OP大鼠的体重增加?目的3)证实OR大鼠增食欲素敏感性的增加是由于增食欲素受体表达增加所致。A)与OP大鼠相比,OR大鼠的食欲素受体数量是否增加?B)OR大鼠RLH增食欲素受体阳性神经元的c-fos活性是否高于OP大鼠?C)减少OR大鼠RLH中食欲素受体阳性神经元的数量是否会增加体重?更好地了解大脑增食欲素及其与SPA在肥胖中的关系,将填补对中枢调节的SPA和NEAT及其对肥胖抵抗的重要性的认识的一大空白。公共卫生相关性目前的提议旨在了解控制身体活动的特定大脑通路的作用,这对体重调节很重要。肥胖是影响至少三分之一美国人口的主要健康问题,也是几种疾病的风险因素,包括心脏病、糖尿病和几种癌症。问题的根本部分是身体活动调节的紊乱,在开发肥胖治疗方法时,有必要更好地了解对此很重要的大脑通路。
英文摘要
DESCRIPTION (provided by applicant): Obesity and overweight affects most Americans, but there are some who resist obesity, just as some animals resist obesity. Animal and human studies indicate that spontaneous physical activity (SPA), which generates nonexercise activity thermogenesis (NEAT), is an important defense against weight gain. Brain mechanisms control the level SPA, and the NEAT so generated, but the specifics are undefined. We propose that hypothalamic orexin A (OxA) is an important part of the SPA regulatory pathway, and that sensitivity to OxA signals enhancing SPA and NEAT helps determine propensity for obesity. The objectives of this application are to test the following hypotheses: (1) elevated OxA mediated SPA protects against weight gain and (2) increased OxA-mediated SPA in obesity resistant (OR) rats results from increased orexin receptor expression. Our long-range goal is to use knowledge of SPA and NEAT regulatory pathways to guide therapeutic interventions on these mechanisms among obese humans. We plan 3 aims: Aim 1) Characterize orexin neuron subpopulations important to SPA. A) Are there strain differences in orexin message and peptide in subpopulations of orexin neurons? B) Does destruction of subpopulations of orexin neurons affect SPA? Aim 2) Determine importance of OxA-mediated SPA to weight gain. A) Does reduced OxA action in rLH of OR rats reduce resistance to weight gain? B) Does SPA induced by high dose OxA stimulation of rLH reduce weight gain in OP rats? Aim 3) Verify that increased orexin sensitivity in OR rats is due to increased orexin receptor expression. A) Is orexin receptor number increased in OR compared to OP rats? B) Is c-fos activation in rLH orexin receptor bearing neurons higher in OR than OP rats? C) Does reducing orexin receptor bearing neurons in rLH of OR rats enhance weight gain? A greater understanding of brain orexin and its relationship to SPA in obesity will fill a large gap in knowledge of centrally mediated SPA and NEAT, and its importance to obesity resistance. PUBLIC HEALTH RELEVANCE The current proposal is aimed at understanding the role of a specific brain pathway that controls physical activity, which is important to body weight regulation. Obesity is a major health problem affecting at least one third of the U.S. population, and is a risk factor for several diseases, including heart disease, diabetes and several types of cancer. Underlying part of the problem is disordered regulation of physical activity, and a better understanding of the brain pathways important to this is necessary in developing treatments for obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing the post weight-loss energy expenditure gap with orexin agonists
  • 批准号:
    10745184
  • 项目类别:
  • 资助金额:
    $73.1万
  • 财政年份:
    2023
  • 负责人:
    CATHERINE M KOTZ
  • 依托单位:
Orexin agonists as novel obesity therapeutics
  • 批准号:
    10655285
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    CATHERINE M KOTZ
  • 依托单位:
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases
  • 批准号:
    10610378
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    CATHERINE M KOTZ
  • 依托单位:
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases
  • 批准号:
    10425193
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    CATHERINE M KOTZ
  • 依托单位:
海外基金